Pancreatic cancer: Pancreatic cancer, especially the adenocarcinoma variety has very poor response to traditional chemo. New drugs and combinations are being developed and approved. Survival appears to be somewhat better with the new therapy. New patients are encouraged to enter clinical trials.
Answered 12/22/2014
4.2k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question